The Summit was jointly hosted by Cohen Veterans Bioscience and Cohen Veterans Network, both leading national non-profit organizations funded by financier-philanthropist Steven A. Cohen to advance the state of Post Traumatic Stress (PTS) & Traumatic Brain Injury (TBI) care today and tomorrow.
This year’s inaugural meeting focused on advancements in bioscience and precision medicine, including opportunities for advancing the PTSD & TBI research roadmap through public-private partnerships.
Participants in this invitation-only event included leaders from academia, Department of Defense, National Institutes of Health, Veterans Administration, foundations and industry.
The tough question she asked herself when starting Cohen Veterans Bioscience, Dr. Magali Haas reported, was “What can this organization bring to the table when billions of dollars are necessary to bring a single CNS drug to market?” Today, the resounding answer is that a patient-driven, nimble and flexible organization adds tremendous value. Embracing the core principles of imagination, integration and acceleration, Cohen Veterans Bioscience is positioned to investigate the biomarker landscape, improve the validity of animal models and harness the complexity of big data using computational modeling methods.
Summit to Address Veterans PTSD-TBI Research and Care
More than 200 thought leaders representing academia, government agencies, the military, industry, and the nonprofit sector will gather on September 22nd and 23rd in Washington, DC to discuss the state of science and care delivery in PTSD and TBI and to map a path to a first generation of diagnostics, therapeutics, and cures.
World-class brain health experts will share the latest research on biomarkers, diagnostics, translational models, genetics, biosensors, and mobile health (including wearable technologies) for PTSD and TBI. Speakers include representatives from the National Institutes of Health, FDA, VA, Department of Defense, U.S. Army, and leading academic institutions — including Columbia, Stanford, Harvard, and NYU. Navy Seals and veterans who have experienced PTSD will also be participating.
It is a critical time for addressing the vast mental health needs of our nation’s veterans. An estimated 20 veterans per day are committing suicide and many more are living for a lifetime with the invisible wounds of war. What is missing from the national discussion of caring for veterans — and all who suffer from PTSD and TBI, which often co-exists with PTSD — is the need for scientific research on its biological mechanisms and that of related conditions. This will lead to the faster development of objective diagnostic tests and more effective treatments.
Please join us for this premier event. [Registration is required]
Cohen Veterans Care Summit
Joining Forces on the Road to Discovery:
Advancing the PTSD Research Agenda
Ronald Reagan Building
1300 Pennsylvania Avenue
September 22nd and 23rd, 2016
(Welcoming remarks begin at 8:00 am)
The event will also be live streamed online at CohenCareSummit.org.
Location: International Gateway Room, Ronald Reagan Building
Cohen Veterans Bioscience
Cohen Veterans Network
The Summit is jointly hosted by Cohen Veterans Bioscience and Cohen Veterans Network, both leading national non-profit organizations funded by billionaire philanthropist, Steven A. Cohen to advance the state of Post Traumatic Stress (PTS) & Traumatic Brain Injury (TBI) care today and tomorrow.
This year’s inaugural meeting will focus on advancements in bioscience and precision medicine and will highlight opportunities for advancing the PTSD & TBI research roadmap through public-private partnerships. World-class brain health experts will share the state-of-the-art in biomarkers, diagnostics, translational models, genetics, biosensors and mobile health for PTSD and TBI. We will also discuss how research advancements can be rapidly translated to best-in-class care delivery.
Participants in this invitation-only event will include leaders from academia, Department of Defense, National Institutes of Health, Veterans Administration, foundations and industry. The agenda includes panel discussions, scientific presentations, and plenty of time for networking with peers to promote innovative collaborations.
Cohen Veterans Bioscience is the only 501(c)(3) non-profit research organization with a singular focus on PTSD and TBI research. We are dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma on the brain. More information is available at www.cohenveteransbioscience.org
Cohen Veterans Network is a 501(c)(3) nonprofit foundation whose mission is to improve the quality of life for post-9/11 veterans and their families by focusing on improving mental health outcomes. The goal of the Cohen Veterans Network is to build a network of free or low-cost outpatient mental health clinics for veterans and their families in high-need communities, in which trained clinicians deliver holistic evidence-based care to treat mental health conditions, especially post-traumatic stress.